Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism
Nutt, John G., Gunzler, Steven A., Kirchhoff, Trish, Hogarth, Penelope, Weaver, Jerry L., Krams, Michael, Jamerson, Brenda, Menniti, Frank S., Landen, Jaren W.
Published in Movement disorders (15.10.2008)
Published in Movement disorders (15.10.2008)
Get full text
Journal Article
Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
Landen, Jaren W, Cohen, Sharon, Billing, Clare B, Cronenberger, Carol, Styren, Scot, Burstein, Aaron H, Sattler, Catherine, Lee, Jae-Hong, Jack, Clifford R, Kantarci, Kejal, Schwartz, Pamela F, Duggan, William T, Zhao, Qinying, Sprenger, Ken, Bednar, Martin M, Binneman, Brendon
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2017)
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2017)
Get full text
Journal Article
Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth
LANDEN, Jaren W, HAU, Vincent, MINGSHEN WANG, DAVIS, Thomas, CILIAX, Brian, WAINER, Bruce H, VAN MEIR, Erwin G, GLASS, Johnathan D, JOSHI, Harish C, ARCHER, David R
Published in Clinical cancer research (01.08.2004)
Published in Clinical cancer research (01.08.2004)
Get full text
Journal Article
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder
Preskorn, Sheldon H, Baker, Bryan, Kolluri, Sheela, Menniti, Frank S, Krams, Michael, Landen, Jaren W
Published in Journal of clinical psychopharmacology (01.12.2008)
Published in Journal of clinical psychopharmacology (01.12.2008)
Get more information
Journal Article
Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XI
Lyden, Patrick, Buchan, Alastair, Boltze, Johannes, Fisher, Marc
Published in Stroke (1970) (01.09.2021)
Published in Stroke (1970) (01.09.2021)
Get full text
Journal Article
Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study
Landen, Jaren W, Zhao, Qinying, Cohen, Sharon, Borrie, Michael, Woodward, Michael, Billing, Jr, Clare B, Bales, Kelly, Alvey, Christine, McCush, Fred, Yang, Jerry, Kupiec, James W, Bednar, Martin M
Published in Clinical neuropharmacology (01.01.2013)
Published in Clinical neuropharmacology (01.01.2013)
Get more information
Journal Article
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
Landen, Jaren W, Andreasen, Niels, Cronenberger, Carol L, Schwartz, Pamela F, Börjesson-Hanson, Anne, Östlund, Henrik, Sattler, Catherine A, Binneman, Brendon, Bednar, Martin M
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2017)
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2017)
Get full text
Journal Article
Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer disease
Burstein, Aaron H, Zhao, Qinying, Ross, Joel, Styren, Scot, Landen, Jaren W, Ma, Wendy W, McCush, Fred, Alvey, Christine, Kupiec, James W, Bednar, Martin M
Published in Clinical neuropharmacology (01.01.2013)
Published in Clinical neuropharmacology (01.01.2013)
Get more information
Journal Article
Burden of illness in fibromyalgia patients with comorbid depression
Bateman, Lucinda, Sarzi-Puttini, Piercarlo, Burbridge, Claire L, Landen, Jaren W, Masters, Elizabeth T, Bhadra Brown, Pritha, Scavone, Joseph M, Emir, Birol, Vissing, Richard S, Clair, Andrew G, Pauer, Lynne R
Published in Clinical and experimental rheumatology (01.03.2016)
Get full text
Published in Clinical and experimental rheumatology (01.03.2016)
Journal Article
Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma
Landen, Jaren W, Lang, Roland, McMahon, Steve J, Rusan, Nasser M, Yvon, Anne-Marie, Adams, Ashley W, Sorcinelli, Mia D, Campbell, Ross, Bonaccorsi, Paola, Ansel, John C, Archer, David R, Wadsworth, Patricia, Armstrong, Cheryl A, Joshi, Harish C
Published in Cancer research (Chicago, Ill.) (15.07.2002)
Get full text
Published in Cancer research (Chicago, Ill.) (15.07.2002)
Journal Article
Enhancing global reliability of the ADAS-cog and MMSE: part 1-the harmonization/standardization project of word lists and phrases
Landen, Jaren W, Schwam, Elias, Evans, Rebecca, Goldman, Rob, SangYun Kim, Mulder, Daniella, Lenderking, William R
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
Evaluation of structural models to describe the effect of placebo upon the time course of major depressive disorder
Shang, Elizabeth Y., Gibbs, Megan A., Landen, Jaren W., Krams, Michael, Russell, Tanya, Denman, Nicholas G., Mould, Diane R.
Published in Journal of pharmacokinetics and pharmacodynamics (01.02.2009)
Published in Journal of pharmacokinetics and pharmacodynamics (01.02.2009)
Get full text
Journal Article
Safety and pharmacokinetics following a single 10-minute intravenous infusion of the anti-amyloid mAb ponezumab (PF-04360365) in patients with mild to moderate Alzheimer's disease
Burstein, Aaron H, Zhao, Qinying, Ross, Joel, Styren, Scot, Landen, Jaren W, Ma, Wendy M, McCush, Frederick, Alvey, Christine, Kupiec, James T, Bednar, Martin M
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
Safety and Pharmacokinetics Following a Single Infusion of the Anti-amyloid Monoclonal Antibody Ponezumab (pf-04360365) in Patients With Mild-to-moderate Alzheimer's Disease: Final Results
Landen, Jaren W, Zhao, Qinying, Cohen, Sharon, Borrie, Michael, Woodward, Michael, Billing, Clare B, Alvey, Christine, Kupiec, James W, Bednar, Martin M
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
The prevalence of brain microhemorrhages and infarcts in a cohort of patients with mild-to-moderate Alzheimer's disease
Bednar, Martin M, Kantarci, Kajal, Kupiec, James T, Burstein, Aaron, Landen, Jaren W, Reyes, Denise, Sattler, Catherine, Bernstein, Matt A, Borowski, Brett, JClifford R. Jack
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
Safety and pharmacokinetics of the anti-amyloid monoclonal antibody PF-04360365 following a single infusion in patients with mild-to-moderate Alzheimer's disease: Preliminary results
Bednar, Martin, Zhao, Qinying, Landen, Jaren W, Billing, Clare B, Rohrbacher, Kevin, Kupiec, James W
Published in Alzheimer's & dementia (01.07.2009)
Published in Alzheimer's & dementia (01.07.2009)
Get full text
Journal Article
IP/MS analysis of human CSF Aβ following a single dose of the C-terminal anti-Aβ antibody ponezumab (PF-04360365) to Alzheimer patients
Wood, Kathleen M, McCush, Frederick, Conboy, James J, Durham, Robert, Tate, Barbara, Bednar, Martin M, Landen, Jaren W, Geoghegan, Kieran F, Bales, Kelly R
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
Preliminary population pharmacokinetic modeling of PF-04360365, a humanized anti-amyloid monoclonal antibody, in patients with mild-to-moderate Alzheimer's disease
Nicholas, Timothy, Knebel, William, Gastonguay, Marc R, Bednar, Martin M, Billing, Clare B, Landen, Jaren W, Kupiec, James W, Corrigan, Brian, Laurencot, Rene, Zhao, Qinying
Published in Alzheimer's & dementia (01.07.2009)
Published in Alzheimer's & dementia (01.07.2009)
Get full text
Journal Article